Healwell AI shares advanced after the company said it demonstrated real-world examples of using artificial intelligence to generate high-quality data for a major pharmaceutical company. Shares traded ...
In the realm of gastroenterology, inflammatory bowel disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), presents a significant therapeutic challenge due to its chronic ...
HEALWELL, in collaboration with Takeda Pharmaceutical, presented new AI generated and regulatory-grade real-world data (RWD) on vedolizumab dose escalation in ulcerative colitis and Crohn's disease at ...
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapiesTopline safety, ...
In a randomized trial, 1 day of octreotide infusion combined with endoscopic therapy proved noninferior to 5 days for acute ...
Everyday Health on MSN
How to Protect Against Blood Clots if You Have Ulcerative Colitis
People with inflammatory bowel disease, like ulcerative colitis, are 2 to 3 times more likely to develop blood clots than ...
When Phyllis Burk was diagnosed with Crohn’s disease nearly 50 years ago, it wasn’t as simple as looking up information ...
Annual fundraiser supports the foundation's efforts to raise awareness and improve quality of life for adults and children ...
Therapeutic drug monitoring is associated with better treatment durability among children with inflammatory bowel diseases.
The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for cases where a patient may not be appropriate for a TNF blocker, drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback